IL17A and cancer: KEGG and the hub gene-pathway network indicated a few signalling pathways, such as cytokine-cytokine receptor interaction, the IL-17 signalling pathway, TNF signalling pathway, transcriptional misregulation in cancer, and chemokine signalling pathway (see Figures 3(c) and 3(f)).